Recruiting Pulmonary Embolism Studies in Flagstaff
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic ef...
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)
Researchers are looking for ways to treat a type of liver disease caused by elevated liver fat, called metabolic dysfunction-associated steatohepatitis (MASH). MASH was formerly called non-alcoholic s...
About Pulmonary Embolism Clinical Trials in Flagstaff
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 2 pulmonary embolism clinical trials recruiting participants in Flagstaff, ARIZONA. These studies are seeking a combined 1,180 participants. Research is being sponsored by Viking Therapeutics, Inc., Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Flagstaff — FAQ
Are there pulmonary embolism clinical trials in Flagstaff?
Yes, there are 2 pulmonary embolism clinical trials currently recruiting in Flagstaff, ARIZONA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Flagstaff?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Flagstaff research site will contact you about next steps.
Are clinical trials in Flagstaff free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Flagstaff studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 2 active trials in Flagstaff are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov